The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Patient (pt) characteristics, treatment patterns, and outcomes in unresectable hepatocellular carcinoma (uHCC) treated with first-line (1L) systemic therapy in the United States (US).
 
Nguyen Tran
Honoraria - Helsinn Therapeutics (Inst); QED Therapeutics (Inst)
Consulting or Advisory Role - AstraZeneca (Inst); Exelixis (Inst); Ipsen (Inst); QED Therapeutics (Inst); TEMPUS (Inst)
Speakers' Bureau - DAVA oncology (Inst)
Research Funding - Exact Sciences
 
Scott Soefje
Honoraria - MJH Life Sciences
Consulting or Advisory Role - BeiGene; GlaxoSmithKline; Regeneron
Research Funding - AstraZeneca; Janssen Oncology
Expert Testimony - Genentech
 
Nivedita Rangarajan
No Relationships to Disclose
 
K Purushotham
No Relationships to Disclose
 
Mihika Nadig
No Relationships to Disclose
 
Tyler Wagner
Employment - Anumana, Inc.; nference
Stock and Other Ownership Interests - Anumana, Inc.; nference
Patents, Royalties, Other Intellectual Property - Patents and patents pending for technologies developed by nference, Inc.
 
Stephen Valerio
Employment - AstraZeneca
Stock and Other Ownership Interests - AstraZeneca
 
Rye Anderson
Employment - AstraZeneca
Stock and Other Ownership Interests - AstraZeneca
 
Jody Olson
No Relationships to Disclose